Latest News

eye on pharma banner
Eye on Pharma: BI Cyltezo Partnership; Europe Ustekinumab Launch; Mexico Biosimilar Approval

July 24th 2024

Boehringer Ingelheim (BI) partners with GoodRx to offer Cyltezo, an adalimumab biosimilar, to patients; a new ustekinumab biosimilar launches in Europe; and Mexican officials approve a bevacizumab biosimilar.

doctor talking about biosimilars | Image credit: Suteren Studio -
Real-World Study: No Increase in Health Resource Costs After Infliximab Biosimilar Introduction

July 20th 2024

doctor patient biosimilar | Image credit: Prostock-studio -
Samsung Bioepis’ Ustekinumab Biosimilar Demonstrates PK Equivalence in Healthy Adults

July 6th 2024

fda approved | Image credit: Argus -
FDA Approves Samsung Bioepis’ Pyzchiva, a Biosimilar to Stelara

July 1st 2024

syringes for subcutaneous injection | Image credit: SOPONE -
Phase 3 Trials Find Subcutaneous Infliximab CT-P13 Superior to Placebo in IBD

June 29th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.